SPAC Lawsuit: What Turns a De-SPAC Deal into Litigation

A SPAC lawsuit often begins with a challenged disclosure, projection, sponsor conflict, or shareholder redemption decision. Claims can surface before closing, after the combined company misses forecasts, or alongside SEC scrutiny. Since 2024, federal rules have materially expanded the disclosure record surrounding de-SPAC transactions, giving courts and regulators more transaction-specific evidence to examine.

A SPAC lawsuit is litigation arising from a SPAC offering, proposed business combination, completed de-SPAC transaction, or the resulting public company.

The defendants and theories vary with the transaction. A complaint may target the SPAC, sponsor, private target, combined company, directors, officers, or other participants. Companies involved in SPAC transactions should therefore distinguish transaction compliance from litigation exposure before a dispute develops.

A falling stock price alone does not establish liability. The legal analysis instead focuses on what was represented, who made or approved it, what information existed at the time, and whether the alleged defect caused legally cognizable harm.

The SEC's current SPAC framework requires more detailed disclosure about the transaction, making disclosure discipline a central litigation-defense issue.

The SEC's Special Purpose Acquisition Companies, Shell Companies, and Projections rules became effective July 1, 2024. As of September 2026, those rules remain the operative SPAC-specific federal framework. Regulation S-K Subpart 1600 addresses sponsor compensation, conflicts, dilution, redemption rights, de-SPAC terms, board determinations, projections, and related matters.

The structured-data phase is also fully operational. Since June 30, 2025, disclosures required under Subpart 1600 must be tagged using Inline XBRL where the rule applies.

Financial projections create risk when their assumptions, preparation history, or continuing validity cannot be reconciled with the disclosure provided to investors.

Regulation S-K Item 1609 requires de-SPAC filings containing projections to identify their purpose and preparer, disclose material bases and assumptions, and address whether the projections still reflect management or board views as of the most recent practicable date before dissemination.

The SEC also amended Item 10(b) of Regulation S-K to address projections more generally, including non-GAAP measures and projections not grounded in historical results. The current record should explain why a particular forecast was used, not merely reproduce the number.

Fiduciary litigation often asks whether sponsor incentives affected the transaction and whether public shareholders received enough information to make an informed redemption decision.

Earlier SPAC cases such as In re MultiPlan Corp. Stockholders Litigation and Delman v. GigAcquisitions3, LLC focused heavily on sponsor economics, allegedly deficient proxy disclosures, and impairment of redemption rights. Those cases shaped the modern SPAC fiduciary litigation model reflected in later disputes.

Corporate-law analysis remains separate from federal securities liability and depends on the entity's state of incorporation.

A SPAC defendant should examine accrual and limitations at the beginning of the case, particularly where the alleged injury was apparent from a proxy statement.

In Reilly v. Horn, the Delaware Supreme Court affirmed dismissal in May 2026, concluding that fiduciary and unjust-enrichment claims tied to an allegedly misleading SPAC proxy accrued when the proxy was disseminated. The three-year limitations period had expired.

The court reinforced that approach on August 25, 2026, in Richards v. Shipwright SPAC I, LLC. It affirmed dismissal where the alleged proxy deficiencies placed the plaintiff on inquiry notice when the proxy was issued.

The closing date is therefore not automatically the correct starting point. A defense chronology should separately identify the proxy date, alleged misstatement, shareholder vote, redemption deadline, closing, corrective disclosures, and complaint date.

An effective response reconstructs the transaction before selecting defenses because different defendants may have possessed different information at different times.

Counsel should map the challenged statements to the person or entity responsible for them, the source materials supporting them, and the statutory elements of each claim.

SPAC defenses are often weakened by an incomplete transaction record or an assumption that all disclosure claims rise and fall together.

Common mistakes include:

• Using boilerplate to defend projections. Item 1609 places greater emphasis on who prepared projections and the assumptions supporting them.
• Preserving only the final model. Drafts may explain changes in revenue, production, customer, financing, or valuation assumptions.
• Equating poor performance with fraud. Later results do not establish what defendants knew when the challenged statement was made.
• Ignoring Macquarie. A Rule 10b-5(b) complaint based on silence should be tested for an actionable statement or half-truth.
• Treating the target and sponsor as one actor. Knowledge, incentives, fiduciary obligations, and statutory exposure may differ.
• Overlooking accrual. Recent SPAC decisions show that proxy dissemination can start the limitations analysis before the transaction closes.
• Delaying D&O notice. Advancement, indemnification, and insurance obligations should be reviewed at the outset.

Parallel contractual or shareholder disputes may also require a broader complex commercial litigation strategy when the SPAC case extends beyond federal securities claims.